These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7083222)

  • 1. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts.
    Houghton JA; Houghton PJ
    Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
    Houghton JA; Tice AJ; Houghton PJ
    Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinoma.
    Houghton JA; Houghton PJ
    Eur J Cancer Clin Oncol; 1983 Jun; 19(6):807-15. PubMed ID: 6191988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
    Kroener JF; Saleh F; Howell SB
    Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
    Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence the therapeutic activity of 5-fluorouracil [6RS]leucovorin combinations in colon adenocarcinoma xenografts.
    Houghton JA; Williams LG; Loftin SK; Cheshire PJ; Morton CL; Houghton PJ; Dayan A; Jolivet J
    Cancer Chemother Pharmacol; 1992; 30(6):423-32. PubMed ID: 1394798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
    Campbell TN; Howell SB; Pfeifle C; House BA
    Cancer Treat Rep; 1982 Sep; 66(9):1723-7. PubMed ID: 7116349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of human tumor xenografts in genetically athymic mice.
    Ovejera AA; Houchens DP; Barker AD
    Ann Clin Lab Sci; 1978; 8(1):50-6. PubMed ID: 623430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
    Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
    Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil (5-FU) and 5,10-methylene tetrahydrofolate (5,10-CH2FH4) as adjuvant therapy in an experimental rodent colon carcinoma model.
    Carlsson G; Hafström LO; Spears CP; Gustavsson B; Larsson PA
    Anticancer Res; 1997; 17(5A):3671-4. PubMed ID: 9413221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA; Maroda SJ; Phillips JO; Houghton PJ
    Cancer Res; 1981 Jan; 41(1):144-9. PubMed ID: 7448754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTX-5-FU combination therapy compared to FUDR monotherapy in nude mice.
    Zanea-Wangler E; Schmitz R; Kesseler J; Ploss HJ
    Strahlenther Onkol; 1989 Jul; 165(7):544-6. PubMed ID: 2526380
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
    Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.
    Peters GJ; Van Dijk J; Nadal JC; Van Groeningen CJ; Lankelma J; Pinedo HM
    In Vivo; 1987; 1(2):113-7. PubMed ID: 2979771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice.
    Rashidi B; An Z; Sun FX; Moossa AR; Hoffman RM
    Clin Cancer Res; 2000 Jun; 6(6):2464-8. PubMed ID: 10873100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.